Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linehan, D. C.
Right arrow Articles by Cody, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linehan, D. C.
Right arrow Articles by Cody, H. S., 3rd

Annals of Surgical Oncology, Vol 6, Issue 5 450-454, Copyright © 1999 by Society of Surgical Oncology


ARTICLES

Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients

D. C. Linehan, A. D. Hill, T. Akhurst, H. Yeung, S. D. Yeh, K. N. Tran, P. I. Borgen and H. S. Cody 3rd
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

BACKGROUND: Radiotracer and blue dye mapping of sentinel lymph nodes (SLN) have been advocated as accurate methods to stage the clinically negative axilla in breast cancer patients. The technical aspects of SLN biopsy are not fully characterized. In this study we compare the results of intraparenchymal (IP) and intradermal (ID) injection of Tc-99m sulfur colloid, to establish an optimal method for SLN localization. METHODS: 200 consecutive patients had SLN biopsy performed by a single surgeon. Of these, 100 (Group I) had IP injection and 100 (Group II) had ID injection of Tc-99m sulfur colloid. All patients had IP injection of blue dye as well. Endpoints included (1) successful SLN localization by lymphoscintigraphy, (2) successful SLN localization at surgery, and (3) blue dye-isotope concordance (uptake of dye and isotope by the same SLN). RESULTS: Isotope SLN localization was successful in 78% of Group I and 97% of group II patients (P < .001). When isotope was combined with blue dye, SLN were found in 92% of group I and 100% of Group II (P < .01). In cases where both dye and isotope were found in the axilla, dye mapped the same SLN as radiotracer in 97% of Group I and 95% of Group II patients. CONCLUSIONS: The dermal and parenchymal lymphatics of the breast drain to the same SLN in most patients. Because ID injection is easier to perform and more effective, this technique may simplify and optimize SLN localization.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
S. Samphao, J. M. Eremin, M. El-Sheemy, and O. Eremin
Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach
Ann. Surg. Oncol., May 1, 2008; 15(5): 1282 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. Suami, W.-R. Pan, G. B. Mann, and G. I. Taylor
The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study
Ann. Surg. Oncol., March 1, 2008; 15(3): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J.-F. Rodier, M. Velten, M. Wilt, P. Martel, G. Ferron, V. Vaini-Elies, H. Mignotte, A. Bremond, J.-M. Classe, F. Dravet, et al.
Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial
J. Clin. Oncol., August 20, 2007; 25(24): 3664 - 3669.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. Sukumvanich, D. J. Bentrem, H. S. Cody III, E. Brogi, J. V. Fey, P. I. Borgen, and M. L. Gemignani
The Role of Sentinel Lymph Node Biopsy in Paget's Disease of the Breast
Ann. Surg. Oncol., March 1, 2007; 14(3): 1020 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. P. Povoski, J. O. Olsen, D. C. Young, J. Clarke, W. E. Burak, M. J. Walker, W. E. Carson, L. D. Yee, D. M. Agnese, R. V. Pozderac, et al.
Prospective Randomized Clinical Trial Comparing Intradermal, Intraparenchymal, and Subareolar Injection Routes for Sentinel Lymph Node Mapping and Biopsy in Breast Cancer
Ann. Surg. Oncol., November 1, 2006; 13(11): 1412 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. D'Eredita, C. Giardina, A. M. Guerrieri, and T. Berardi
A Further Validation of Subareolar Injection Technique for Breast Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., May 1, 2006; 13(5): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. A. Newman
Sentinel Lymph Node Biopsy for Breast Cancer: Will Variations in Technique Influence Long-Term Outcome?
Ann. Surg. Oncol., September 1, 2005; 12(9): 686 - 688.
[Full Text] [PDF]


Home page
Arch SurgHome page
A. Pinero, J. Illana, C. Garcia-Palenciano, F. Canizares, M. Canteras, V. Canadillas, E. Duran, and P. Parrilla
Effect on Oximetry of Dyes Used for Sentinel Lymph Node Biopsy: Are There Differences?
Arch Surg, November 1, 2004; 139(11): 1204 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. Chagpar, R. C. Martin III, C. Chao, S. L. Wong, M. J. Edwards, T. Tuttle, and K. M. McMasters
Validation of Subareolar and Periareolar Injection Techniques for Breast Sentinel Lymph Node Biopsy
Arch Surg, June 1, 2004; 139(6): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
N. M. Hansen, X. Ye, B. J. Grube, and A. E. Giuliano
Manipulation of the Primary Breast Tumor and the Incidence of Sentinel Node Metastases From Invasive Breast Cancer
Arch Surg, June 1, 2004; 139(6): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Suga, Y. Yuan, M. Okada, N. Matsunaga, A. Tangoku, S. Yamamoto, and M. Oka
Breast Sentinel Lymph Node Mapping at CT Lymphography with Iopamidol: Preliminary Experience
Radiology, February 1, 2004; 230(2): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac
Clinical Breast Lymphoscintigraphy: Optimal Techniques for Performing Studies, Image Atlas, and Analysis of Images
RadioGraphics, January 1, 2004; 24(1): 121 - 145.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. D'Eredita', F. Ferrarese, V. Cecere, S. T. Massa, F. de Carne, and G. Fabiano
Subareolar Injection May Be More Accurate Than Other Techniques for Sentinel Lymph Node Biopsy in Breast Cancer
Ann. Surg. Oncol., October 1, 2003; 10(8): 942 - 947.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Brenot-Rossi, G. Houvenaeghel, J. Jacquemier, V.-J. Bardou, M. Martino, N. Hassan-Sebbag, and J. Pasquier
Nonvisualization of Axillary Sentinel Node During Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer?
J. Nucl. Med., August 1, 2003; 44(8): 1232 - 1237.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. Liberman
Lymphoscintigraphy for Lymphatic Mapping in Breast Carcinoma
Radiology, August 1, 2003; 228(2): 313 - 315.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Simmons, S. Thevarajah, M. B. Brennan, P. Christos, and M. Osborne
Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization
Ann. Surg. Oncol., April 1, 2003; 10(3): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Bonnema and C. J. H. van de Velde
Sentinel lymph node biopsy in breast cancer
Ann. Onc., October 1, 2002; 13(10): 1531 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
N. M. Hansen, B. J. Grube, and A. E. Giuliano
The Time Has Come to Change the Algorithm for the Surgical Management of Early Breast Cancer
Arch Surg, October 1, 2002; 137(10): 1131 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. L. Quan, D. McCready, W. J. Temple, and J. G. McKinnon
Biology of Lymphatic Metastases in Breast Cancer: Lessons Learned From Sentinel Node Biopsy
Ann. Surg. Oncol., June 1, 2002; 9(5): 467 - 471.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, D. J. Carlson, A. L. Laidley, T. Q. McGlothin, P. B. Ley, C. M. Brown, et al.
The Effect of Prior Breast Biopsy Method and Concurrent Definitive Breast Procedure on Success and Accuracy of Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., April 1, 2002; 9(3): 272 - 277.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. W. Bauer, F. R. Spitz, L. S. Callans, A. Alavi, R. Mick, S. P. Weinstein, I. Bedrosian, D. L. Fraker, T. L. Bauer, and B. J. Czerniecki
Subareolar and Peritumoral Injection Identify Similar Sentinel Nodes for Breast Cancer
Ann. Surg. Oncol., March 1, 2002; 9(2): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. M. Tuttle, M. Colbert, R. Christensen, K. J. Ose, T. Jones, R. Wetherille, J. Friedman, K. Swenson, and K. M. McMasters
Subareolar Injection of 99mTc Facilitates Sentinel Lymph Node Identification
Ann. Surg. Oncol., January 1, 2002; 9(1): 77 - 81.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. D. Nathanson, D. L. Wachna, D. Gilman, K. Karvelis, S. Havstad, and J. Ferrara
Pathways of Lymphatic Drainage From the Breast
Ann. Surg. Oncol., December 1, 2001; 8(10): 837 - 843.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. H. Chung, W. Ye, and A. E. Giuliano
Role for Sentinel Lymph Node Dissection in the Management of Large (>=5 cm) Invasive Breast Cancer
Ann. Surg. Oncol., October 1, 2001; 8(9): 688 - 692.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. Liberman and H. S. Cody III
Percutaneous Biopsy and Sentinel Lymphadenectomy: Minimally Invasive Diagnosis and Treatment of Nonpalpable Breast Cancer
Am. J. Roentgenol., October 1, 2001; 177(4): 887 - 891.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. D. McCarter, H. Yeung, S. Yeh, J. Fey, P. I. Borgen, and H. S. Cody III
Localization of the Sentinel Node in Breast Cancer: Identical Results With Same-Day and Day-Before Isotope Injection
Ann. Surg. Oncol., September 1, 2001; 8(8): 682 - 686.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. C.G. Martin, J. Fey, H. Yeung, P. I. Borgen, and H. S. Cody III
Highest Isotope Count Does Not Predict Sentinel Node Positivity in All Breast Cancer Patients
Ann. Surg. Oncol., August 1, 2001; 8(7): 592 - 597.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Mariani, L. Moresco, G. Viale, G. Villa, M. Bagnasco, G. Canavese, J. Buscombe, H. W. Strauss, and G. Paganelli
Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery
J. Nucl. Med., August 1, 2001; 42(8): 1198 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. R. Byrd, L. K. Dunnwald, D. A. Mankoff, B. O. Anderson, R. E. Moe, R. S. Yeung, E. K. Schubert, and J. F. Eary
Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy
Ann. Surg. Oncol., April 1, 2001; 8(3): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. Shen, E. C. Glass, L. A. DiFronzo, and A. E. Giuliano
Dermal Versus Intraparenchymal Lymphoscintigraphy of the Breast
Ann. Surg. Oncol., April 1, 2001; 8(3): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Hodgson, P. Zabel, A.G. Mattar, C.J. Engel, D. Girvan, and R. Holliday
A New Radiocolloid for Sentinel Node Detection in Breast Cancer
Ann. Surg. Oncol., March 1, 2001; 8(2): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. W.D. Yeung, H. S. Cody III, A. Turlakow, E. R. Riedel, J. Fey, M. Gonen, R. Nuñez, S. D. Yeh, and S. M. Larson
Lymphoscintigraphy and Sentinel Node Localization in Breast Cancer Patients: A Comparison Between 1-Day and 2-Day Protocols
J. Nucl. Med., March 1, 2001; 42(3): 420 - 423.
[Abstract] [Full Text]


Home page
Ann. Surg. Oncol.Home page
B. J. Grube and A. E. Giuliano
Modification of the Sentinel Node Technique: It Was a Hit in New York, But Will It Play in Poughkeepsie?
Ann. Surg. Oncol., January 1, 2001; 8(1): 3 - 6.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. S. Cody III, J. Fey, T. Akhurst, M. Fazzari, M. Mazumdar, H. Yeung, S. D.J. Yeh, and P. I. Borgen
Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures
Ann. Surg. Oncol., January 1, 2001; 8(1): 13 - 19.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. K. Boolbol, J. V. Fey, P. I. Borgen, A. S. Heerdt, L. L. Montgomery, M. Paglia, J. A. Petrek, H. S. Cody III, and K. J. Van Zee
Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast Carcinoma
Ann. Surg. Oncol., January 1, 2001; 8(1): 20 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Cserni
Axillary staging of breast cancer and the sentinel node
J. Clin. Pathol., October 1, 2000; 53(10): 733 - 741.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. M. Guenther, J. C. Collins, G. Barnes Jr, and T. X. O'Connell
Selective Lymphoscintigraphy: A Necessary Adjunct to Dye-Directed Sentinel Node Biopsy for Breast Cancer?
Arch Surg, September 1, 2000; 135(9): 1101 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
G. Cserni, M. Rajtar, and G. Boross
Blue Nodes Left Behind After Vital Blue Dye-guided Axillary Sentinel Node Biopsy in Breast Cancer Patients
Jpn. J. Clin. Oncol., June 1, 2000; 30(6): 263 - 266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.